Imprimis Pharmaceuticals Inc (IMMY.OQ)

IMMY.OQ on NASDAQ Stock Exchange Capital Market

8.30USD
19 Dec 2014
Price Change (% chg)

$-0.12 (-1.43%)
Prev Close
$8.42
Open
$8.27
Day's High
$8.44
Day's Low
$8.22
Volume
2,129
Avg. Vol
3,793
52-wk High
$9.44
52-wk Low
$3.06

IMMY.OQ

Chart for IMMY.OQ

About

Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company’s Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company’s lead pain product,... (more)

Overall

Beta: -1.19
Market Cap (Mil.): $76.82
Shares Outstanding (Mil.): 9.26
Dividend: --
Yield (%): --

Financials

  IMMY.OQ Industry Sector
P/E (TTM): -- 179.07 38.47
EPS (TTM): -1.02 -- --
ROI: -68.11 -0.72 18.25
ROE: -69.51 -1.88 19.13
Search Stocks

Competitors

  Price Change
Eli Lilly and Co (LLY.N) $72.40 -0.05
Sanofi SA (SASY.PA) €75.38 --
Bayer AG (BAYGn.DE) €114.00 -1.00
Bayer AG (BAYE.F) -- --
Roche Holding Ltd. (ROG.VX) CHF270.40 -18.30
Merck & Co., Inc. (MRK.N) $59.58 +0.60
Novartis AG (NOVN.VX) CHF93.05 +0.95

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks